Autor: |
Monahan RC; Department of Internal Medicine, Alrijne Hospital, location Leiderdorp, the Netherlands., Suttorp MM, Gabreëls BATF |
Jazyk: |
angličtina |
Zdroj: |
The Netherlands journal of medicine [Neth J Med] 2017 May; Vol. 75 (4), pp. 169-171. |
Abstrakt: |
Rivaroxaban is a direct oral anticoagulant that is prescribed for the prevention and treatment of thromboembolisms. Rivaroxaban is cleared renally and a common side effect (1-10%) is renal impairment of unknown pathophysiology. We are the first to describe a case of biopsy-proven acute tubulointerstitial nephritis, most likely caused by rivaroxaban. |
Databáze: |
MEDLINE |
Externí odkaz: |
|